Antibody Library Technologies Market - Global Size, Share, Trends, Growth and Forecast Year ( 2022 – 2032 )
Antibody Library Technologies Market by Technology (Phage Display, Ribosome Display, Yeast Display, Mammalian Cell Display), Application (Research Applications, Drug discovery and development, Other), End-user Industry (Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations), and Geographic Regions (North America, Europe, Asia Pacific, Latin America, Middle East and Africa): Industry Trends and Global Forecasts, 2023-2032.
Antibody Library Technologies Market Size and Overview:
The antibody library technologies market is poised to exhibit steady progress and grow at a compound annual growth rate (CAGR) of 4.0% during the period from 2023 to 2032. As per the data provided by KD Market Insights, the market value of antibody library technologies market reached USD 226.9 million in 2032. This growth can be attributed to the increasing prevalence of advanced cancer treatment, increasing healthcare expenditure, growing demand for antibody library technologies, and technological advancements. The market is divided into various segments, such as technology, application, end-user industry, and geographical regions.
Antibody Library Technologies Market Report Scope
USD 153.3 Million
USD 226.9 Million
4.0% from 2023 to 2032
- Phage Display
- Ribosome Display
- Yeast Display
- Mammalian Cell Display
- Research Applications
- Drug discovery and development
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Phage Display: Based on technology, the phage segment acquires the largest share of the antibody library market. Antibody fragments are linked to the bacteriophage coat protein in phage display technology. The phage-displayed antibody libraries available in the commercial market are HuCAL (MorphoSys AG), Llama VHH Nave Library (Abzena Plc.), and others.
Drug Discovery and Development: Based on application, the drug discovery and development segment holds the largest share in the antibody library technologies market. The drug discovery and development in the biological sciences major funding comes from government funds and research funding, which is driving the market.
The regional analysis of the Antibody Library Technologies Market reveals diverse trends and dynamics across different parts of the world. The North American market holds the largest market share for antibody library technologies. The United States is a significant market in this region. Due to the increase in healthcare spending, the market is growing faster. Other factors driving the market are the increasing prevalence of chronic diseases such as blood diseases and cardiovascular diseases. Europe is also a leading market, with Germany as a significant market in the region. The market is driven by increasing healthcare spending and the presence of key market players in the region. The Asia-Pacific region is expected to be the fastest-growing region in the antibody library technologies market. China, being a significant market, is promoting the development of antibody libraries to advance cancer immunotherapy.
Due to the limitations and shortcomings of conventional molecular display technologies, new display-less technologies have been developed. The separation of antibodies with affinities as low as subnanomolar has been done successfully by the approaches of display-less technologies. The faster-automated selection of high-affinity binders in less time will be possible through new developments in technologies. This will boost the market for antibody library technologies. The growing demand for antibody library technologies in various parts of the world, especially in the United States, is booming the market growth. The increasing healthcare expenditure due to rising concerns for health and government initiatives toward healthcare infrastructure is also leading to market growth. The rising prevalence of cancer with the rising need of advance cancer treatments is creating a high demand for the antibody library technology market.
The phage display system technology is highly biased as it is excessively redundant and is more laborious in terms of candidate identification. The MAB produced in vitro is not used in the display system methods because of the lack of awareness of regulatory pathways. This lack of knowledge leads to a major challenge for small biotechnology companies that have potential therapeutic MAB candidates but could not commercialize them.
- XOMA Corporation
- AvantGen Inc.
- MorphoSys AG
- Philogen SpA
- AnaptyBio Inc.
- Invenra Inc.
- Adimab LLC
- AxiMx Inc.
- Abgent Inc. (WuXi AppTec company)
- Vaccinex Inc.
- Abzena Plc.
The report profiles leading companies in the Antibody Library Technologies Market, such as Creative-Biolabs, XOMA Corporation, AvantGen Inc., and others. To gain higher revenues and expand the sales footprint in emerging economies, the leading companies, as well as the local market players in the antibody library market, are focusing on adopting different promotional strategies. Manufacturing companies are adopting several strategies like collaborations, agreements, partnerships, and research scholarships to increase product sales worldwide.
In November 2020, MorphoSys, Xencor, and Incyte collaborated on the global development of Tafasitamab in combination with Plamotamad.